Development and cross-cohort evaluation of a <i>DLX4</i>-associated epithelial-mesenchymal transition pathomics signature for overall survival in clear cell renal cell carcinoma.
- DOI
- 10.21037/tau-2026-0653
- Published
- 2026-09-28
- Container
- Transl Androl Urol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tau-2026-0653,
title = {Development and cross-cohort evaluation of a \<i\>DLX4\</i\>-associated epithelial-mesenchymal transition pathomics signature for overall survival in clear cell renal cell carcinoma.},
author = {Fang G and Bao X and Chang J and Sun F and Qiu Z.},
year = {2026},
journal = {Transl Androl Urol},
doi = {10.21037/tau-2026-0653},
url = {https://doi.org/10.21037/tau-2026-0653}
}RIS
TY - JOUR TI - Development and cross-cohort evaluation of a <i>DLX4</i>-associated epithelial-mesenchymal transition pathomics signature for overall survival in clear cell renal cell carcinoma. AU - Fang G AU - Bao X AU - Chang J AU - Sun F AU - Qiu Z. PY - 2026 JO - Transl Androl Urol DO - 10.21037/tau-2026-0653 UR - https://doi.org/10.21037/tau-2026-0653 ER -
APA
G, F., X, B., J, C., F, S., & Z., Q. (2026). Development and cross-cohort evaluation of a <i>DLX4</i>-associated epithelial-mesenchymal transition pathomics signature for overall survival in clear cell renal cell carcinoma.. Transl Androl Urol. https://doi.org/10.21037/tau-2026-0653
Source records
- europe-pmc · retrieved 2026-11-10T11:59:47.731Z